Hepatitis B Reactivation in Chronic Hepatitis C Patients during Treatment with Ledipasvir and Sofosbuvir

Gane E.J. , Hyland R.H. , An D. , Svarovskaia E.S. , Brainard D. , McHutchison J.G. Ledipasvir and sofosbuvir for HCV-infection in patients coinfected with HBV. Antivir Ther 2016; 21: 605–609.

Konstantinou D. , Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viral interactions and management. Ann Gastroenterol 2015; 28: 221–228.

Pontisso P. , Gerotto M. , Ruvoletto M.G. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 1996; 48: 157–160.

Zhu W. , Wu C. , Deng W. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo. PLoS One 2012; 7: e45146.

Chen S.Y. , Kao C.F. , Chen C.M. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003; 278: 591–607.

Collins J.M. , Raphael K.L. , Terry C. Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir. Clin Infect Dis 2015; 61: 1304–1306.

Ende A.R. , Kim N.H. , Yeh M.M. Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report. J Med Case Rep 2015; 9: 164.

Takayama H. , Sato T. , Ikeda F. Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection. Hepatol Res 2016; 46: 489–491.

De Monte A. , Courjon J. , Anty R. Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge. J Clin Virol 2016; 78: 27–30.

Hayashi K. , Ishigami M. , Ishizu Y. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis? Clin J Gastroenterol 2016; 9: 252–256.